Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study
Stephen J. Schuster(UPMC Hillman Cancer Center), Constantine S. Tam(Peter MacCallum Cancer Centre), Peter Borchmann(University Hospital Cologne), Nina Worel(Medical University of Vienna), Joseph P. McGuirk(University of Kansas), Harald Holte(Oslo University Hospital), Edmund K. Waller(Emory University), Samantha Jaglowski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Michael Bishop(University of Chicago), Lloyd E. Damon(University of California, San Francisco), S.R. Foley(McMaster University), Jason R. Westin(The University of Texas MD Anderson Cancer Center), Isabelle Fleury(Hôpital Maisonneuve-Rosemont), P. Joy Ho(University of Sydney), Stephan Mielke(University of Würzburg), Takanori Teshima(Hokkaido University Hospital), Murali Janakiram(University of Minnesota), Jing-Mei Hsu(New York Hospital Queens), Koji Izutsu(Tokyo National Hospital), Marie José Kersten(University of Amsterdam), Monalisa Ghosh(Michigan Medicine), Nina D. Wagner‐Johnston(Johns Hopkins University), Koji Kato(Kyushu University Hospital), Paolo Corradini(Fondazione IRCCS Istituto Nazionale dei Tumori), Marcela Martínez-Prieto(Novartis (United States)), Xia Han(Novartis (United States)), Ranjan Tiwari(Novartis (India)), Gilles Salles(Hospices Civils de Lyon), Richard T. Maziarz(Oregon Health & Science University)
Cited by 555
Abstract
Related Papers
No related papers found
Powered by citation graph analysis